... Model ( https://dbpia.nl.go.kr/pages/standard-publication-reuse-rights ) Abstract Background and Aims High-sensitivity cardiac troponin (hs-cTn) assays are crucial in assessing suspected myocardial infarction (MI). International recommendations recommend evaluating new assays to identify metrics...

... Model ( https://dbpia.nl.go.kr/pages/standard-publication-reuse-rights ) Abstract Background High-sensitivity cardiac troponin (hs-cTn) assays indicating myocardial injury are critical for the diagnosis of acute myocardial infarction (AMI), but their use to differentiate between acute and chronic...

...% CI 3–15%). Conclusion Our discovery approach has translated IGFBP-3 as a potential biomarker to identify significant CAD/ischaemia in patients who do not meet diagnostic thresholds for MI. Graphical Abstract Graphical Abstract Biomarker IGFBP-3 Troponin Imaging Acute coronary syndromes...

...Peter E Hickman; Julia M Potter; Louise Cullen; Kai M Eggers; Martin Than; John W Pickering; William Parsonage; Jenny Doust Corresponding author. Email: j.doust@uq.edu.au Abstract The 99th percentile of cardiac troponin assays for determining the presence of acute myocardial infarction (AMI...

...—for further information please contact journals.permissions@oup.com. Abstract Aims This prospective, two-centre study derived and validated predictive algorithms for the Siemens Atellica IM high-sensitivity cardiac troponin I (hs-cTnI) assay in the emergency department (ED). Methods and results...

... myocardial infarction. Compared with patients without myocardial infarction, those with secondary myocardial infarction were older, had more risk factors, and had higher troponin concentrations (P < 0.05 for all). During a median follow-up of 4.4 years, death, myocardial infarction, or heart...

... 16 06 2024 18 08 2024 04 11 2024 As cardiac troponin is generally only measured in patients with the highest pre-test probability where the clinician reasonably suspects myocardial injury or ischaemia, the true prevalence of myocardial injury and type 2 MI may be higher. In the CHARIOT...

...Benjamin Bay; Luise Pieper; Alina Goßling; Kevin Kaatze; Caroline Kellner; Natalie Arnold; Christopher Blaum; Julia Rohde; Lukas Köster; Thiess Lorenz; Tanja Zeller; Stefan Blankenberg; Christoph Waldeyer; Fabian J Brunner More recently, troponin levels quantified through high-sensitivity troponin...

... RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. Abstract Background Heterophile antibody presence confounds troponin assay results, causing falsely elevated troponin levels. This rare phenomenon...

...) are a leading cause of presentation to Emergency Departments (ED). However, the incidence of acute myocardial infarction (MI) in this population is low. ¹ Current European guidelines for management of ACS recommend using serial (at presentation and 1 or 2 h later) high-sensitivity cardiac troponin...

... FOR LONG FORMS OF CARDIAC TROPONIN T; T.P.: lectures for Astra Zeneca; T.H.: lectures for AstraZeneca, Astellas, and GSK and pending patent application WO2023187258 (A1)—ASSAY FOR LONG FORMS OF CARDIAC TROPONIN T; T.V.: pending patent application WO2023187258 (A1)—ASSAY FOR LONG FORMS OF CARDIAC TROPONIN T...

... in protocol development, data collection, analysis, or manuscript writing. During the 16-week study period, there were 4768 presentations with a troponin measurement (2376 presentations usual-care; 2392 intervention). The mean (SD) age was 62.0 years (18.5 years), and 49.7% were female. The mean age...

...; Daniel L Jacoby; Stephen B Heitner; Stuart Kupfer; Fady I Malik; Lisa Meng; Amy Wohltman; James L Januzzi; on behalf of the SEQUOIA-HCM Investigators Natriuretic peptides Troponin Hypertrophic cardiomyopathy Aficamten Cytokinetics, Incorporated 10.13039/100014941 Adolph Hutter Professorship...

... by CMR in 2019. Stratified by sex, ACE 1950 participants from quartiles having the lowest and the highest cardiac troponin at baseline were included. Only participants who at baseline had no overt angina or coronary artery disease, defined as self-reported history of myocardial infarction or coronary...

... disease. CI, confidence interval; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; hs-cTnT, high-sensitivity cardiac troponin T. Myocardial infarction High-sensitivity cardiac troponin T Chronic kidney disease Wayne and Kathryn Preisel Chair in Cardiovascular Disease Research See...

... Cardiac troponin plays an essential role in the management of non-ST segment elevation acute coronary syndrome (NSTE-ACS). However, it is not clear whether troponin concentrations provide guidance regarding the initiation of prognostically beneficial cardiovascular medications [i.e. betablockers, renin...

...-of-care (POC) high-sensitivity cardiac troponin I (hs-cTnI) assay may expedite emergency care. A 2-h POC hs-cTnI strategy for emergency patients with suspected AMI was derived and validated. Methods In two international, multi-centre, prospective, observational studies of adult emergency patients...

... atherosclerosis with high-sensitivity cardiac troponin as a quantitative biochemical marker of myocardial injury provided incremental value in the detection of functionally relevant coronary artery disease (fCAD) and risk stratification. Methods and results Consecutive patients undergoing myocardial perfusion...

... from the baseline survey interview date until the first of either death registration date or the study end date (31 December 2019). The NHANES programme released the high-sensitivity cardiac troponin (hs-cTn) dataset in September 2022. ¹³ This dataset included measurements of hs-cTn in all...

...-hospital rule-out of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) with point-of-care (POC) troponin measurement in low-risk patients reduces 30-day healthcare costs. The incidence of major adverse cardiac events (MACE) at 30 days after pre-hospital rule-out of NSTE-ACS in low-risk...